Ashwagandha — Research Evidence
The summary below was generated by an AI system (Claude) based on the studies listed. It is a synthesis tool, not a clinical opinion. Read individual studies for full context.
Ashwagandha (Withania somnifera) is a root herb from Ayurvedic medicine, classified as an adaptogen — a category describing botanicals proposed to help the body resist physical and psychological stressors. Its primary bioactive constituents are withanolides, a class of steroidal lactones that appear to modulate the hypothalamic-pituitary-adrenal (HPA) axis, the central hormonal stress response system.
The strongest evidence for ashwagandha relates to stress reduction and cortisol lowering. A well-designed double-blind RCT (Chandrasekhar et al., 2012, n=64) found that a standardized ashwagandha root extract (300 mg twice daily for 60 days) significantly reduced Perceived Stress Scale scores, serum cortisol, and self-reported anxiety and stress compared to placebo. Effect sizes were clinically meaningful in this population. Similar findings have been reported in other RCTs using standardized extracts such as KSM-66 and Sensoril, though trial sizes remain modest (n=40–100 range) and most are of relatively short duration (8–12 weeks).
Sleep quality is an emerging area of evidence. A 2019 RCT (Langade et al., n=60) found ashwagandha (300 mg twice daily, KSM-66 extract, 10 weeks) significantly improved sleep onset latency, total sleep time, and sleep efficiency versus placebo, with secondary improvements in anxiety. This aligns with the herb's observed mild sedating quality, which may also explain the preference among practitioners for evening dosing.
Testosterone and strength outcomes in men have some RCT support. Wankhede et al. (2015, n=57) found greater 1-RM strength gains, a modest testosterone increase, and reduced post-exercise creatine kinase in men taking KSM-66 alongside resistance training. These findings require replication and should be interpreted with caution — the testosterone effect was statistically significant but modest in absolute terms, and the study was conducted exclusively in males.
Several important caveats apply across the ashwagandha evidence base. Most trials use proprietary standardized extracts (KSM-66, Sensoril) with defined withanolide content — results may not generalize to non-standardized powders or preparations with different phytochemical profiles. Industry funding is present in multiple trials, which warrants independent replication. Additionally, there is limited long-term safety data (beyond 3 months), and case reports have raised questions about potential thyroid hormone modulation, though the clinical significance in euthyroid individuals is unclear. Some practitioners recommend cycling (approximately 8–12 weeks on, followed by a 4-week break) as a precautionary approach.
Ashwagandha is not established as safe in pregnancy — it was traditionally used as an abortifacient in some systems, and human safety data in pregnant women is absent. It should be avoided during pregnancy.
Key findings
- ✓Double-blind RCT (n=64) found significant reductions in perceived stress, anxiety, and serum cortisol at 300 mg twice daily for 60 days.
- ✓RCT (n=60) supports improvements in sleep onset, total sleep time, and sleep efficiency with standardized KSM-66 extract over 10 weeks.
- ✓RCT in men (n=57) found modest testosterone increase and greater strength gains when combined with resistance training.
- ✓Most evidence comes from standardized proprietary extracts (KSM-66, Sensoril) — generalizability to all ashwagandha products is limited.
- ✓Some practitioners recommend cycling based on limited long-term data and theoretical thyroid interaction concerns.
Evidence gaps
- ?Long-term safety data (beyond 12 weeks) is limited; no large longitudinal studies exist.
- ?Most trials are small (n<100), industry-sponsored, and of short duration — independent replication is needed.
- ?Thyroid hormone interaction is a theoretical concern with limited clinical data; euthyroid individuals may not be affected at typical doses.
- ?No studies in pregnant women; avoidance is recommended.
- ?Head-to-head comparisons of KSM-66 vs. Sensoril vs. non-standardized preparations are absent.
- ?Effects in women have been less studied than in men — some findings (particularly testosterone) may not translate.
Safety summary
Ashwagandha is generally recognized as safe at studied doses (300–600 mg/day of standardized extract) over 8–12 weeks in healthy non-pregnant adults. Mild GI upset is the most commonly reported side effect. Case reports of liver injury have been published, though these are rare and causality is difficult to establish. Caution is warranted in individuals with thyroid disorders or those on thyroid medication, as ashwagandha may influence thyroid hormone levels. Avoid during pregnancy. Cycling (approximately 12 weeks on, 4 weeks off) is a reasonable precautionary approach given limited long-term data. Consult a healthcare provider if you have autoimmune conditions, take immunosuppressants, or have liver disease.
Studies (3)
A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults
High-concentration full-spectrum ashwagandha root extract (300 mg twice daily for 60 days) significantly reduced PSS scores, serum cortisol levels, and scores on the anxiety and stress subscales of DASS-21 compared to placebo. No serious adverse events were reported.
May reduce perceived stress, anxiety, and serum cortisol in adults with chronic stress
Well-tolerated in this trial; mild GI complaints in a small number of participants
Relatively small n=64; single study center; used full-spectrum extract (KSM-66 type) — not directly generalizable to all ashwagandha products
Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Insomnia and Anxiety: A Double-blind, Randomized, Placebo-controlled Study
Ashwagandha root extract (KSM-66, 300 mg twice daily for 10 weeks) significantly improved sleep onset latency, total sleep time, sleep efficiency, and morning alertness compared to placebo. Anxiety scores were also significantly lower in the treatment group.
May improve sleep onset, sleep duration, and sleep quality, with secondary benefit on anxiety
No serious adverse events; well-tolerated across both healthy volunteers and insomnia patients
Small n=60; relatively short duration (10 weeks); single standardized extract form used — generalizability to other preparations is uncertain
Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial
Ashwagandha supplementation (300 mg twice daily of KSM-66 for 8 weeks) was associated with significantly greater gains in muscle strength (1-RM), testosterone levels, and lean mass compared to placebo. Muscle damage marker (creatine kinase) post-exercise was also lower in the treatment group.
May support muscle strength gains, recovery, and testosterone levels in men engaged in resistance training
Well-tolerated; no serious adverse events in this study
Male-only population; single form of extract; 8-week duration; testosterone effect size was modest and its clinical significance uncertain